Ricardo
Torres Peral
Profesor Asociado CC. Salud
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (7)
2024
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
-
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP
European Journal of Pediatrics
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
“Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain”
Human Immunology, Vol. 84, Núm. 4, pp. 290-295
2022
-
Correlation of Anti-Tissue Transglutaminase Antibodies With the Mucosal Changes and IgA Status of Children With Celiac Disease
Journal of pediatric gastroenterology and nutrition, Vol. 75, Núm. 6, pp. 743-748
2021
-
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study (European Journal of Pediatrics, (2021), 180, 9, (3029-3038), 10.1007/s00431-021-04063-6)
European Journal of Pediatrics
-
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
European Journal of Pediatrics, Vol. 180, Núm. 9, pp. 3029-3038